Download PDF
Thromb Haemost 1979; 41(03): 475-490
DOI: 10.1055/s-0038-1646800
Original Articles
Schattauer GmbH Stuttgart

The Action Mechanism of the Purified Platelet Aggregation Principle of Trimeresurus mucrosquamatus Venom

Chaoho Ouyang
The Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, Republic of China
,
Che-Ming Teng
The Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, Republic of China
› Author Affiliations
Further Information

Publication History

Received 11 October 1977

Accepted 10 August 1978

Publication Date:
09 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The minimal concentration of the platelet aggregation principle (Platelet Aggregoserpen- tin, PAS) necessary to induce platelet aggregation was 10 ng/ml, about one-hundredth of that of the crude venom. PAS induced the release of platelet factors 3 and 4 from platelets, but the released platelet factor 3 was easily inactivated by the anti-phospholipid effect of PAS. Pretreatment of platelets with neuraminidase potentiated PAS-induced platelet aggregation. PAS-induced platelet aggregation was independent on released ADP; it could occur in the ADP-removing systems, such as apyrase or a combination of phosphoenolpyruvate and pyruvate kinase. However, PAS-induced platelet aggregation could be inhibited by adenine nucleotides and adenosine.

PAS-induced platelet aggregation was inhibited by some anti-inflammatory agents, antimalarial drugs, local anesthetics, antihistamine and smooth muscle relaxants. After deaggregation of PAS-treated platelets, thrombin and sodium arachidonate could further induce platelet aggregation, but ADP and second dose of PAS could not. It is concluded that PAS-induced platelet aggregation is due to prostaglandin synthesis. Recent literatures on the mechanism of platelet aggregation were surveyed and the actions of PAS were discussed.

 

  • References

  • 1 Aledort LM, Niemetz J. 1968; Dissociation of platelet aggregation from clot retraction, potassium loss, and adenosine triphosphatase activity. Proceedings of the Society for Experimental Biology and Medicine 128: 658
    PubMedSearch in Google Scholar
  • 2 Ardlie NG, Glew G, Schultz BG, Schwartz CJ. 1967; Inhibition and reversal of platelet aggregation by methylxanthines. Thrombosis et Diathesis Haemorrhagica 18: 670
    PubMedSearch in Google Scholar
  • 3 Ardlie NG, Perry DW, Packham MA, Mustard JF. 1971; Influence of apyrase on stability of suspensions of washed rabbit platelets. Proceedings of the Society for Experimental Biology and Medicine 136: 1021
    PubMedSearch in Google Scholar
  • 4 Biran H, Dvilansky A, Nathan I, Live A. 1974; Impairement of human platelet aggregation and serotonin release caused in vitro by Echis colorata venom. Thrombosis et Diathesis Haemorrhagica 30: 191
    PubMedSearch in Google Scholar
  • 5 Boffa MC, Boffa GA. 1974 Correlations between the enzymatic and factors active on blood coagulation and platelet aggregation from the venom of Vipera aspis. Biochimica et Biophysica Acta.
    PubMedSearch in Google Scholar
  • 6 Boffa MC, Delori P, Soulier JP. 1972; Anticoagulant factors from Viperidae venoms. Platelet phospholipid inhibitors. Thrombosis et Diathesis Haemorrhagica 28: 509
    PubMedSearch in Google Scholar
  • 7 Bond GH, Hudgins PM. 1976; Inhibition of ATPase activity in human red cell membranes by tetracaine. Biochemical Pharmacology 25: 267
    CrossrefPubMedSearch in Google Scholar
  • 8 Born GV R, Cross MJ. 1963; The aggregation of blood platelet. Journal of Physiology 168: 178
    CrossrefPubMedSearch in Google Scholar
  • 9 Bradlow BA, Marcus AJ. 1966; Action of snake venom phospholipase A on isolated platelet membranes. Proceedings of the Society for Experimental Biology and Medicine 123: 889
    PubMedSearch in Google Scholar
  • 10 Cohen P, Derksen A. 1969; Comparison of phospholipid and fatty acid composition of human erythrocytes and platelets. British Journal of Haematology 17: 359
    CrossrefPubMedSearch in Google Scholar
  • 11 Condrea E, De Vries A, Mayer J. 1962; Action of snake venom phospholipase A on free and lipoprotein-bound phospholipids. Biochimica et Biophysica Acta 58: 389
    CrossrefPubMedSearch in Google Scholar
  • 12 Davey MG, Lüscher EF. 1965; Action of some coagulant snake venoms upon blood platelets. Nature (London) 207: 1037
    CrossrefPubMedSearch in Google Scholar
  • 13 Davey MG, Luscher EF. 1967; Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature (London) 216: 857
    CrossrefPubMedSearch in Google Scholar
  • 14 Davis JW, Yue KT N, Phillips PE. 1972; The effect of neuraminidase on platelet aggregation induced by ADP, norepinephrine, collagen or serotonin. Thrombosis et Diathesis Haemorrhagica 28: 221
    PubMedSearch in Google Scholar
  • 15 Day HJ, Holmsen H, Zucker MB. 1975; Methods for separating platelets from blood and plasma. Thrombosis et Diathesis Haemorrhagica 33: 648
    PubMedSearch in Google Scholar
  • 16 Derksen A, Cohen P. 1975; Patterns of fatty acid release from endogenous substrates by human platelet homogenates and membranes. Journal of Biological Chemistry 250: 9342
    PubMedSearch in Google Scholar
  • 17 Didisheim P, Kazmier FJ, Fuster V. 1974; Platelet inhibition in the management of thrombosis. Thrombosis et Diathesis Haemorrhagica 32: 21
    PubMedSearch in Google Scholar
  • 18 Feinstein M, Fiekers J, Fraser C. 1976; An analysis of the mechanism of local anesthetic inhibition of platelet aggregation and secretion. Journal of Pharmacology and Experimental Therapeutics 197: 215
    PubMedSearch in Google Scholar
  • 19 Flower RJ, Blackwell GJ. 1976; The importance of phospholipase A2 in prostaglandin biosynthesis. Biochemical Pharmacology 25: 285
    CrossrefPubMedSearch in Google Scholar
  • 20 Greenberg J, Packham MA, Cazenave JP, Reimers HJ, Mustard JF. 1975; Effects on platelet function of removal of platelet sialic acid by neuraminidase. Laboratory Investigations 32: 476
    PubMedSearch in Google Scholar
  • 21 Hamberg M, Svensson J, Samuelsson B. 1975; Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proceedings of the National Academy of Sciences 72: 2994
    CrossrefPubMedSearch in Google Scholar
  • 22 Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. 1974; a Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proceedings of the National Academy of Sciences 71: 345
    CrossrefPubMedSearch in Google Scholar
  • 23 Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. 1974; b Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. Proceedings of the National Academy of Sciences 71: 3400
    CrossrefPubMedSearch in Google Scholar
  • 24 Hampton J. 1971; Trends in the development of antithrombotic agents. American Journal of Cardiology 27: 659
    CrossrefPubMedSearch in Google Scholar
  • 25 Harbury CB, Hershagold JE, Schrier SL. 1972; Requirements for aggregation of washed human platelets suspended in buffered salt solutions. Thrombosis et Diathesis Haemorrhagica 28: 2
    PubMedSearch in Google Scholar
  • 26 Haslam RJ. 1964; Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids. Nature 202: 765
    CrossrefPubMedSearch in Google Scholar
  • 27 Haslam RJ. 1973; Interactions of the pharmacological receptors of blood platelets with adenyl cyclase. Seminar Haematologica 6: 333
    PubMedSearch in Google Scholar
  • 28 Haslam RJ, Lynham JA. 1972; Activation and inhibition of blood platelet adenylate cyclase by adenosine or by 2-chloroadenosine. Life Science 11: 1143
    CrossrefPubMedSearch in Google Scholar
  • 29 HIRSH J, GENT M, GENTON E. 1975; The current status of platelet suppressive drugs in the treatment of thrombosis. Thrombosis et Diathesis Haemorrhagica 33: 406
    PubMedSearch in Google Scholar
  • 30 Hovig T. 1963; Aggregation of rabbit blood platelets produced in vitro by “saline extract” of tendons. Thrombosis et Diathesis Haemorrhagica 9: 248
    PubMedSearch in Google Scholar
  • 31 Jesse RL, Cohen P. 1976; Arachidonic acid release from diacyl phosphatidylethanolamine by human platelet membranes. Biochemical Journal 158: 283
    CrossrefPubMedSearch in Google Scholar
  • 32 Kazimierczak W, Peret M, Máslínski C. 1976; The action of local anesthetics on histamine release. Biochemical Pharmacology 25: 1747
    CrossrefPubMedSearch in Google Scholar
  • 33 Kirschmann C, Aloof S, De Vries A. 1963; Action of lysolecithin on blood platelets. Thrombosis et Diathesis Haemorrhagica 9: 512
    PubMedSearch in Google Scholar
  • 34 Kirschmann C, Condrea E, Moau N. 1964; Action of snake venom on human platelet phospholipids. Archives of the International Pharmacodyn 150: 372
    PubMedSearch in Google Scholar
  • 35 Kolata GB. 1975; Thromboxanes: The power behind the prostaglandins. Science 190 770: 812
    PubMedSearch in Google Scholar
  • 36 Leone G, Boni P, Vinceti A. 1976; Platelet aggregation by thimerosal, role of ADP and SH groups. Thrombosis and Haemostasis 35: 249
    Thieme ConnectPubMedSearch in Google Scholar
  • 37 Macfarlane DE, Mills DC B. 1975; The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation. Blood 46: 309
    PubMedSearch in Google Scholar
  • 38 Macmillan DC. 1966; Secondary clumping effect in human citrated platelet-rich plasma produced by ADP and adrenaline. Nature (London) 211: 140
    CrossrefPubMedSearch in Google Scholar
  • 39 Markus HB, Ball EG. 1969; Inhibition of lypolytic process in rat diphose tissue by antimalarial drugs. Biochimica et Biophysica Acta 187: 486
    CrossrefPubMedSearch in Google Scholar
  • 40 Markwardt F, Barthel W, Glusa E, Hoffmann A. 1966; N-S Archives of Experimental Pathology. Pharmacology 252: 297
    PubMedSearch in Google Scholar
  • 41 Markwardt F, Hoffmann A. 1970; Effects of papaverine derivatives on cyclic AMP phosphodiesterase of human platelets. Biochemical Pharmacology 19: 2519
    CrossrefPubMedSearch in Google Scholar
  • 42 Marney SR. 1971; Platelet aggregation in heparinized plasma and citrated plasma. Relationship to ADP and inhibition by cobra factor. Journal of Immunology 106: 82
    PubMedSearch in Google Scholar
  • 43 Mcnicol GP, Mitchell JR A, Reuter H, Van De Loo J. 1970; Platelet in thrombosis, their clinical significance and the evaluation of potential drugs. Thrombosis et Diathesis Haemorrhagica 31: 379
    PubMedSearch in Google Scholar
  • 44 Meyer CJ, Van Breemen C, Casteels R. 1972; The action of Lanthanum and D600 on the calcium exchange in the smooth muscle cells of the guinea-pig taenia coli. Pflueeers Archives 337 333
    PubMedSearch in Google Scholar
  • 45 Michel H, Caen JP, Born GV R, Miller R, Auriac GA, Meyer P. 1976; Relation between the inhibition of aggregation and the concentration of c-AMP in human and rat platelets. British Journal of Haematology 33: 27
    CrossrefPubMedSearch in Google Scholar
  • 46 Mustard JF, Perry DW, Ardlie NG, Packham MA. 1972; Preparation of suspensions of washed platelets from humans. British Journal of Haematology 22: 193
    CrossrefPubMedSearch in Google Scholar
  • 47 Nye SW, Graham JB, Brinkhous KM. 1962; The partial thromboplastin time as a screening test for the detection of latent bleeders. American Journal of Medical Science 243: 279
    CrossrefPubMedSearch in Google Scholar
  • 48 O’Brien JR. 1962; Platelet aggregation. II. Some results from a new method of study. Journal of Clinical Pathology 15: 452
    CrossrefPubMedSearch in Google Scholar
  • 49 Ouyang C, Teng CM. 1977 Purification and characterization of the platelet aggregation principle of Trimeresurus mucrosquamatus venom. Submitted for publication in Biochimica et Biophysica Acta.
    PubMedSearch in Google Scholar
  • 50 Packham MA, Warrior ES, Glynn MF, Senyi AS, Mustard JF. 1967; Alternation of the response of platelet to surface stimuli by pyrazole compounds. Journal of Experimental Medicine 126: 171
    CrossrefPubMedSearch in Google Scholar
  • 51 Patscheke H, Brossmer R. 1975; Concanavalin A-induced aggregation of human blood platelets. Ca++-dependent and Ca++-independent effects. Thrombosis et Diathesis Haemorrhagica 33: 354
    PubMedSearch in Google Scholar
  • 52 Praga CA, Pogliani EM. 1973; Effect of temperature on ADP-induced platelet aggregation. Thrombosis et Diathesis Haemorrhagica 29: 183
    PubMedSearch in Google Scholar
  • 53 Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF. 1976; In vitro and in vivo functions of thrombin-treated platelets. Thrombosis et Diathesis Haemorrhagica 35: 151
    PubMedSearch in Google Scholar
  • 54 Roth GJ, Majerus PW. 1975; The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particular fraction protein. Journal of Clinical Investigation 56: 624
    CrossrefPubMedSearch in Google Scholar
  • 55 Salzman EW, Levine L. 1971; Cyclic 3’,5’-adenosine monophosphate in human blood platelets. II. Effect of N6-2’-0-dibutyryl cyclic 3’,5’-adenosine monophosphate on platelet function. Journal of Clinical Investigation 50: 131
    CrossrefPubMedSearch in Google Scholar
  • 56 Samuelsson B, Granström E, Green K, Hamberg M, Hammarström S. 1975; Annual Review of Biochemistry. 44: 669
    PubMedSearch in Google Scholar
  • 57 Saxon A, Kattlove HE. 1976; Platelet inhibition by sodium nitroprusside, a smooth muscle inhibitor. Blood 47. 951
    PubMedSearch in Google Scholar
  • 58 Shtacher G, Crowley HJ, Dolton C. 1976; Inhibition of platelet aggregation by papaverinelike drugs: evidence for a novel mechanism of action. Biochemical Pharmacology 25: 1045
    CrossrefPubMedSearch in Google Scholar
  • 59 Simard-Duquesne N. 1973; Enhancement by ADP of thrombin-induced aggregation in ADP- refractory platelets. Thrombosis et Diathesis Haemorrhagica 29: 445
    PubMedSearch in Google Scholar
  • 60 Sket D, Gubensek F. 1976; Pharmacological study of phospholipase A from Vipera ammodytes venom. Toxicon 14: 393
    CrossrefPubMedSearch in Google Scholar
  • 61 Strong PN, Goerke J, Oberg G, Kelly RB. 1976; P-Bungarotoxin, a pre-synaptic toxin with enzymatic activity. Proceedings of the National Academy of Sciences USA 73: 178
    CrossrefPubMedSearch in Google Scholar
  • 62 Thomson D, Forbes CD, Prentice CR M. 1973; A comparison of the effects of antihistamines on platelet function. Thrombosis et Diathesis Haemorrhagica 30: 547
    PubMedSearch in Google Scholar
  • 63 Ungaro PC, Beck TM, Mccaa WM, Hershagold EJ. 1973; The in vivo and in vitro effect of antihistamines on platelet aggregation. Thrombosis et Diathesis Haemorrhagica 30: 597
    PubMedSearch in Google Scholar
  • 64 Vane JR. 1971; Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (New Biology) 231: 232
    PubMedSearch in Google Scholar
  • 65 Vargaftic BB, Hai ND. 1972; Selective inhibition by mepacrine of the release of »rabbit aorta contracting substance« evoked by the administration of bradykinin. Journal of Pharmacy and Pharmacology 24: 159
    CrossrefPubMedSearch in Google Scholar
  • 66 Verhaeghe RH, Shepherd JT. 1976; Effect of nitroprusside on smooth muscle and adrenergic nerve terminals in isolated blood vessels. Journal of Pharmacology Experimental Therapeutics 199: 269
    PubMedSearch in Google Scholar
  • 67 Warlow C, Corina A, Ogston D, Douglas AS. 1974; The relationship between platelet aggregation and time interval after venepuncture. Thrombosis and Diathesis Haemorrhagica 31: 133
    PubMedSearch in Google Scholar
  • 68 WEISS HJ. 1976; Antiplatelet drugs - A new pharmacologic approach to the prevention of thrombosis. American Heart Journal 92: 86
    CrossrefPubMedSearch in Google Scholar
  • 69 Yue KT N, Davis JW, Aldridge EG. 1973; Effect of aspirin and benadryl on human platelet oxidative phosphorylation and aggregation. Thrombosis et Diathesis Haemorrhagica 30: 577
    PubMedSearch in Google Scholar
  • 70 Zucker MB, Peterson J. 1968; Inhibition of adenosine diphosphate induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proceedings of the Society of Experimental Biology and Medicine 127: 547
    PubMedSearch in Google Scholar